# Advance at a glance: contributions to cardio-oncology

**Authors:** Joerg Herrmann

PMC · DOI: 10.1093/ehjopen/oeaf075 · 2025-06-20

## Full-text entities

- **Diseases:** STEMI (MESH:D000072657), communicable diseases (MESH:D003141), Non-Hodgkin's lymphoma (MESH:D008228), CV death (MESH:D003643), breast (MESH:D061325), lung cancer (MESH:D008175), breast cancer (MESH:D001943), thrombotic (MESH:D013927), infarction (MESH:D007238), CVD (MESH:D002318), cardiac arrhythmias (MESH:D001145), colon and prostate cancer (MESH:D011471), Myocardial Infarction (MESH:D009203), re (MESH:D000084063), Hypertension (MESH:D006973), heart failure (MESH:D006333), coronary and peripheral vascular disease (MESH:D016491), pulmonary embolism (MESH:D011655), ischaemic stroke (MESH:D002544), CM (MESH:D009202), Bleeding (MESH:D006470), heart valve disease (MESH:D006349), AF (MESH:D001281), NCDs (MESH:D000073296), MPNs (MESH:D009369), cardiotoxicity (MESH:D066126)
- **Chemicals:** anthracycline (MESH:D018943), ACEI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12204645